Keywords = Multiple sclerosis
The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ebrahim Kouchaki; Nasim Safa


A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ali Motahharynia; Ahmad Pourmohammadi; Armin Adibi; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei


Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mahshid Mahyad; Mohammad Ali Nahayati; Maryam Ebrahimian


Artificial intelligence in multiple sclerosis imaging: advancements, benefits, and challenges (PP-07)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Kimia Kazemzadeh


A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Taraneh Mousavi; Behzad Fatemi; Shekoufeh Nikfar; Mohammad Ali Sahraian


Benign Paroxysmal Positioning Vertigo in Multiple Sclerosis (PP-09)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fatemeh Jafarlou


Cardiovascular autonomic dysfunction in MS (PP-10)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Ashraf Zarvani; Nasim Tabrizi


Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Neda Ramezani; Elahe Ahmadikhonsaraki; Atoosa Khosravi; Alireza Taghdisi Kashani; Azam Eshaghian-Dorcheh; Zahra Karimi; Saba Naghavi; Ghazal Zandieh; Ahmad Pourmohammadi; Amirhossein Davarpanah Jazi; Iman Adibi


Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

K. Bahrami; Mohammad Ali Nahayati; Mohammad Shriati


Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammadreza Malek Zadeh; Pourandokht Mousavian; Mohammad Ali Nahayati


Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mehran Rashidi Alavijeh; Saba Naghavi; Neda Ramazani; Sayed Mohsen Hosseini; Iman Adibi


The Effect of Multiple Sclerosis on Peripheral Audio-Vestibular System (PP-17)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fatemeh Jafarlou


Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Sara Yazdani; Mohsen Foroughipour


Headache first manifestation of Multiple Sclerosis (PP-19)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fatemeh Abrishamchi


Investigating the relationship between stress, anxiety and depression with the quality (PP-20)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Majid Jafari; Masoud Lotfizadeh; Razieh Hashemi


Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Sepideh Paybast; Fatemeh Baghalha; Ali Emami; Abdorreza Naser Moghadasi


Lingual dystonia as the first manifestation of multiple sclerosis (PP-22)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Farid Shamlou


MS and exercise (PP-23)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Maryam Abolhasani; Farzin Halabchi


Multidisciplinary rehabilitative management (PP-24)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Razieh Pirzad


Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fardin Nabizadeh; Elham Ramezannezhad; Kimia Kazemzadeh; Elham Khalili; Elham Moases Ghaffary; Omid Mirmosayyeb


Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Elham Sadat Azimi


Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Farinaz Tabibian; Kiarash Azimzadeh; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei


Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Amir Ali Gharemani


Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammad Yazdan Panah; Saeed Vaheb; Yousef Mokary; Elham Moases Ghaffary; Alireza Afshari-Safavi; Aysa Shaygannejad; Narges Ebrahimi; Vahid Shaygannejad; Omid Mirmosayyeb


Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Maryam Mohaghegh; Mohammad Hossein Sanati; Mitra Ataei; Mehdi Sadeghi; Shokoufeh Alayi